GIPC1 and breast carcinoma: Moreover, GIPC1 silencing correlates with marked reductions in cell viability and evaluations in caspase 3/7 activities in MCF-7 and SKBR-3 human breast cancer and SW480 and SW620 human colorectal cancer cells.